Influence of Faradarmani Consciousness Field on Spatial Memory and Passive Avoidance Behavior of Scopolamine Model of Alzheimer Disease in Male Wistar Rats

Alzheimer's disease (AD) is a growing public health concern, affecting millions of patients worldwide and costing billions of dollars annually. There is a pressing need to find effective treatment strategies for AD. In the 1980s, Mohammad Ali Taheri introduced novel fields with a non-material, non-energetic nature, named Taheri Consciousness Fields (TCFs). One of these fields, Faradarmani Consciousness Field (FCF), has been introduced as a complementary medicine, and its effects can be investigated through reproducible laboratory experiments. In this study, we evaluated the influence of FCF on scopolamine-induced memory impairments in male Wistar rats. Rats were divided into four groups (n=10 each). The scopolamine groups received a single injection of scopolamine (SCP) (5 mg/kg) intraperitoneally one hour before the test. Rats in the FCF groups were exposed to this treatment one day before the administration of scopolamine. The passive avoidance and Morris water maze (MWM) tests were conducted to evaluate memory function in the scopolamine-induced rats. The results of passive avoidance and MWM tests revealed that scopolamine induced a decline in spatial memory and cognitive function. Whereas, rats treated by FCF spent more time in target zone and the step through latency was significantly greater than SCP group without FCF. Moreover, rats had lower velocity which may be related to the reduction in stress under FCF. Overall, FCF could significantly ameliorate scopolamine-induced cognitive impairment. Further experiments are required to investigate how exactly this field influence memory at the molecular level.